Botulinum toxin type B (Myobloc). [Dermatol Surg. 2003]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Dermatol Surg. 2003 May;29(5):496-500; discussion 500. Links

Botulinum toxin type B (Myobloc).

Baumann L, Black L.

Division of Cosmetic Dermatology, University of Miami, Miami, Florida, USA.

Myobloc, known as Neurobloc in Europe, is a member of the botulinum toxin family. It has been used for a myriad of problems since its approval in the United States in December 2000. It is currently not approved for cosmetic use but has been used for this purpose. This article reviews what is currently known about botulinum toxin type B and its efficacy and safety.

PMID: 12752517 [PubMed - indexed for MEDLINE]

ReviewBotulinum toxin-B and the management of hyperhidrosis.
Clin Dermatol. 2004 Jan-Feb; 22(1):60-5.

[Clin Dermatol. 2004]
ReviewReview of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
Clin J Pain. 2002 Nov-Dec; 18(6 Suppl):S191-7.

[Clin J Pain. 2002]
Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Int J Dermatol. 2005 May; 44(5):418-24.

[Int J Dermatol. 2005]
ReviewThe cosmetic use of botulinum toxin type B.
Int Ophthalmol Clin. 2005 Summer; 45(3):153-61.

[Int Ophthalmol Clin. 2005]
Comparison of botulinum toxins A and B in the treatment of facial rhytides.
Dermatol Clin. 2004 Apr; 22(2):221-6.

[Dermatol Clin. 2004]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Botulinum toxin type B (Myobloc).Botulinum toxin type B (Myobloc).

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Botulinum toxin type B (Myobloc).

Related articles

Recent Activity